Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
Jianghua Zhou, Lan Bai, Xiaojing Zhang, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2839-2847
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 2, pp. 180-191
Open Access | Times Cited: 80
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 24
Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
Pervej Alom Barbhuiya, Ameena Ahmed, Partha Dutta, et al.
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Closed Access | Times Cited: 1
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
Søren Møller, Nina Kimer, Jens D. Hove, et al.
European Journal of Preventive Cardiology (2025)
Closed Access | Times Cited: 1
Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study
Yuling Xing, Jinhu Chen, Jing Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 383-394
Open Access | Times Cited: 33
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy
Ze Chen, Zhaoxia Jin, Jingjing Cai, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 12, pp. 1721-1739
Closed Access | Times Cited: 30
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 4, pp. 968-968
Open Access | Times Cited: 28
Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study
Shouling Wu, Yuhao Li, Yijun Zhang, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 2
Closed Access | Times Cited: 7
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China
Fang Lei, Juan‐Juan Qin, Xiaohui Song, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Impact of NAFLD and its pharmacotherapy on lipid profile and CVD
Zhenya Wang, Mao Ye, Xiao‐Jing Zhang, et al.
Atherosclerosis (2022) Vol. 355, pp. 30-44
Open Access | Times Cited: 24
Fatty liver disease, heart rate and cardiac remodelling: Evidence from the UK Biobank
Oveis Jamialahmadi, Federica Tavaglione, Araz Rawshani, et al.
Liver International (2023) Vol. 43, Iss. 6, pp. 1247-1255
Open Access | Times Cited: 13
Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases
Yufeng Hu, Wei Li, Xu Cheng, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 222-260
Closed Access | Times Cited: 5
A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease
Naoki Shibata, Yasuhiro Morita, Takanori Ito, et al.
European Journal of Internal Medicine (2024) Vol. 129, pp. 62-70
Closed Access | Times Cited: 5
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
Qin Li, Junru Wu, Xuejing Sun, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
The Pan-liver Network Theory
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 12
How non-alcoholic fatty liver disease and cirrhosis affect the heart
Søren Møller, Signe Wiese, Mads Barløse, et al.
Hepatology International (2023) Vol. 17, Iss. 6, pp. 1333-1349
Closed Access | Times Cited: 11
Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies
Charilila-Loukia Ververeli, Yannis Dimitroglou, Στέργιος Σουλαϊδόπουλος, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 812-812
Open Access
Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis
Parham Dastjerdi, Mehrdad Mahalleh, Hedieh Shayesteh, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access
Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study
Xuan-Yu Wang, Qiong Lyu, Yangyang Zhang, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 2
Open Access
Efficacy of traditional Chinese medicine-based clearing heat and laxative method against nonalcoholic fatty liver disease: A systematic review and meta-analysis
Ya-Nan Qu, Yan-Jing Liu, Jiatong Sun, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42189-e42189
Open Access
High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation
Raphaël Decoin, Laura Butruille, Thomas Defrancq, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 16
Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk
Felix Westcott, David Dearlove, Leanne Hodson
Atherosclerosis (2023) Vol. 394, pp. 117237-117237
Open Access | Times Cited: 10
Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure
Gerui Li, Zhengjie Lu, Ze Chen
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease.
Dmitry Victorovich Garbuzenko
PubMed (2022) Vol. 15, Iss. 3, pp. 194-203
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top